Goldman Updates 2013 EPS Estimate for Express Scripts

Goldman Sachs updated its 2013 earnings-per-share estimates for Express Scripts, Inc. ESRX today, maintaining its Buy Rating. The analysts appeared not to view the change as very substantive, as they held to their investment thesis, rating and price target. Goldman's revised 2013 EPS outlook for ESRX now sits at $4.52. With a price target of $62.00, ESRX still has some room to grow. The stock is trading at $52.88 as of 1:17PM today.